March 18, 2020 09:58 AM EDTUpdated March 19, 04:31 AM
R&D
Coronavirus

Covid-19 roundup: Trump back­tracks on NIH/CDC fund­ing, No­var­tis launch­es $20M fund, FDA and ICER can­cel­la­tions

Jason Mast

Editor

An­oth­er day, an­oth­er batch of coro­n­avirus news. To­day: A $20 mil­lion Big Phar­ma pledge, new vac­cine and drug hunts, and can­cel­la­tions from ICER and the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times